SheshadriMadhusudhanaMD

Assistant Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine

Dr. Madhusudhana is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2310 Holmes St
Ste 500
Kansas City, MO 64108
Phone+1 816-404-4375

Fax+1 816-404-4337

University of Missouri-Kansas City School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2005 - 2008
JSS Medical College MysoreClass of 1998

PubMed

47 citations
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer...
Priyanka Sharma, Bruce F. Kimler, Anne O'Dea, Lauren Nye, Yen Y. Wang
Clinical Cancer Research. 2021-02-15
16 citations
Searching for cures: Inner-city and rural patients' awareness and perceptions of cancer clinical trials
Mugur V. Geana, Joseph Erba, Hope Krebill, Gary C. Doolittle, Sheshadri Madhusudhana
Contemporary Clinical Trials Communications. 2017-03-01
104 citations
Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.
Sashidhar Manthravadi, Anuj Shrestha, Sheshadri Madhusudhana
International Journal of Cancer. 2016-09-15

Abstracts/Posters

The Utilization of Screening Tests for Plasma Cell Dyscrasias By Internal Medicine Physicians at a Teaching Hospital
Sheshadri Madhusudhana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019